Tarsus Pharmaceuticals, Inc. (TARS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Core Insights - The company is a few years into the launch of its product XDEMVY, indicating a relatively recent entry into the market [1] Company Overview - Tarsus is the company in focus, and there is a request for an overview of its operations and timeline regarding the approval and launch of XDEMVY [1]